» Articles » PMID: 8593442

Thrombolytic Effect of Nattokinase on a Chemically Induced Thrombosis Model in Rat

Overview
Journal Biol Pharm Bull
Specialty Biochemistry
Date 1995 Oct 1
PMID 8593442
Citations 34
Authors
Affiliations
Soon will be listed here.
Abstract

Nattokinase is a new fibrinolytic enzyme which cleaves directly cross-linked fibrin in vitro. In this study, we investigated the thrombolytic effect of nattokinase on a thrombus in the common carotid artery of rat in which the endothelial cells of the vessel wall were injured by acetic acid. When a section of occluded vessel was stained for CD61 antigen by immunofluorescence utilizing a monoclonal antibody, the antigen was localized around the surface of the occluded blood vessels. This result suggests that the occlusive thrombosis was caused by platelet aggregation. In addition, thrombolysis with urokinase (UK; 50000 IU/kg, i.v.) or tissue plasminogen activator (tPA; 13300 IU/kg, i.v.) in our model was observed to restore the blood flow over a 60 min monitoring period. The results indicate that our chemically induced model is useful for screening and evaluating a thrombolytic agent. We evaluated the thrombolytic activity of nattokinase using this model and compared it with fibrino(geno)lytic enzyme, plasmin or elastase. On a molar basis, the recovery of the arterial blood flow with nattokinase, plasmin and elastase were 62.0 +/- 5.3%, 15.8 +/- 0.7% and 0%, respectively. The results indicate that the thrombolytic activity of nattokinase is stronger than that of plasmin or elastase in vivo.

Citing Articles

Natural serine proteases and their applications in combating amyloid formation.

Metkar S, Udayakumar S, Girigoswami A, Girigoswami K ADMET DMPK. 2024; 12(6):797-820.

PMID: 39713256 PMC: 11661804. DOI: 10.5599/admet.2551.


Comparative Cardioprotective Effectiveness: NOACs vs. Nattokinase-Bridging Basic Research to Clinical Findings.

Muric M, Nikolic M, Todorovic A, Jakovljevic V, Vucicevic K Biomolecules. 2024; 14(8).

PMID: 39199344 PMC: 11352257. DOI: 10.3390/biom14080956.


Nattokinase Supplementation and Cardiovascular Risk Factors: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Li X, Long J, Gao Q, Pan M, Wang J, Yang F Rev Cardiovasc Med. 2024; 24(8):234.

PMID: 39076715 PMC: 11266782. DOI: 10.31083/j.rcm2408234.


Effect of nattokinase on the pathological conditions in streptozotocin induced diabetic rats.

Yamaguchi M, Fukuyama R, Fujita M Heliyon. 2024; 10(7):e28835.

PMID: 38586318 PMC: 10998082. DOI: 10.1016/j.heliyon.2024.e28835.


Development of novel natto using legumes produced in Europe.

Rocchi R, Zwinkels J, Kooijman M, Garre A, Smid E Heliyon. 2024; 10(5):e26849.

PMID: 38463896 PMC: 10923668. DOI: 10.1016/j.heliyon.2024.e26849.